DAA581 |
polymerase (DNA-directed), delta interacting protein 3 |
Molecular |
skeletal muscle |
Human |
POLDIP3 |
5.0% Increase Gene Expression Level |
|
DAA582 |
selenium binding protein 1 |
Molecular |
skeletal muscle |
Human |
SELENBP1 |
7.0% Increase Gene Expression Level |
|
DAA583 |
tripartite motif-containing 15 |
Molecular |
skeletal muscle |
Human |
TRIM15 |
18.0% Increase Gene Expression Level |
|
DAA584 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
Molecular |
skeletal muscle |
Human |
UQCRFS1 |
4.0% Decrease Gene Expression Level |
|
DAA585 |
ubiquinol-cytochrome c reductase hinge protein |
Molecular |
skeletal muscle |
Human |
UQCRH |
4.0% Decrease Gene Expression Level |
|
DAA586 |
xeroderma pigmentosum, complementation group C |
Molecular |
skeletal muscle |
Human |
XPC |
6.0% Increase Gene Expression Level |
|
DAA642 |
Muscle atrophy (sarcopenia) |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA643 |
Muscle fiber energy metabolism declines |
Physiological |
skeletal muscle |
Human |
— |
— |
|
DAA644 |
Tendons' ability to elongate decreases |
Physiological |
tendon |
Human |
— |
— |
|
DAA645 |
Bone remodeling decreases |
Physiological |
bone |
Human |
— |
— |
|
DAA646 |
Osteoporosis: progressive loss of bone strength |
Physiological |
bone |
Human |
— |
— |
|
DAA647 |
Bone resorption increases for cortical bone |
Physiological |
bone |
Human |
— |
— |
|
DAA648 |
Bone mass decreases |
Physiological |
bone |
Human |
— |
— |
|
DAA649 |
Bone mineral density in cortical ulna decreases |
Physiological |
ulna |
Human |
— |
— |
|
DAA650 |
Bone density of total hip and femoral neck decreases |
Physiological |
bone |
Human |
— |
— |
|
DAA651 |
Bone porosity increases |
Physiological |
bone |
Human |
— |
— |
|
DAA652 |
Mineralization of bone tissue increases |
Physiological |
bone |
Human |
— |
— |
|
DAA653 |
Bone becomes more brittle, less flexible |
Physiological |
bone |
Human |
— |
— |
|
DAA654 |
Fractures are cleaner |
Physiological |
bone |
Human |
— |
— |
|
DAA655 |
Hip fracture risk increases |
Pathological |
femur |
Human |
— |
— |
|
DAA656 |
Synovial fluid alterations |
Physiological |
synovium |
Human |
— |
— |
|
DAA657 |
Osteoarthritis |
Pathological |
joint |
Human |
— |
— |
|
DAA658 |
Cartilage color changes |
Physiological |
cartilage |
Human |
— |
— |
|
DAA659 |
Cell number decreases in cartilage |
Physiological |
cartilage |
Human |
— |
— |
|
DAA660 |
Cartilage joint surface cracks and frays |
Physiological |
cartilage |
Human |
— |
— |
|